Special Seminar: Regulation of Targeted Therapies for Patients with Myeloid Malignancies
Kelly Norsworthy, M.D.
Acting Director
Division of Hematologic Malignancies I
Office of Oncologic Diseases, Office of New Drugs
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Regulation of Targeted Therapies for Patients with Myeloid Malignancies
Date: April 23, 2026
Time: 2 p.m.
In-person: Collaboratory, 3rd Floor, Children’s National Research and Innovation Campus
Virtual: Join via Zoom
About this Seminar
Dr. Norsworthy will discuss FDA's regulation of targeted therapies for myeloid malignancies, focusing on drug approvals for genetically defined biomarker subsets. She will cover FDA approval requirements and clinical endpoints for acute myeloid leukemia, myelodysplastic syndromes, and chronic myeloid leukemia. Her presentation will highlight how biomarkers are integrated throughout drug development—from early discovery to pivotal trials and regulatory approval.
You May Also Be Interested In...
-
Home Item
A Nicotine-Focused Regulatory Strategy: The Science , homeMarch 13, 2026, 11:00 a.m. | Dorothy Hatsukami, Ph.D., Professor of Psychiatry and Behavioral Sciences and Forster Family Chair in Cancer Prevention, Masonic Cancer Center, University of Minnesota | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke
-
Home Item
From BDNF to Rett Syndrome: Synapses, Networks, and Social Behaviors in Mecp2 Mutant Mice , homeMarch 27, 2026, 11:00 a.m. | Lucas Pozzo-Miller, Ph.D., Mall Family Endowed Professor for Genetic Autism Research, Department of Pediatrics & Human Development, College of Medicine, Michigan State University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research
-
Home Item
The Effects of Aging and Physical Activity on Cardiovascular Structure and Function , homeApril 10, 2026, 11:00 a.m. | Ben Levine, M.D., Professor of Medicine and Cardiology, Clinical Heart and Vascular Center, Distinguished Professorship in Exercise Sciences, UT Southwestern Medical Center | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home Item
The Golden Age of Immunology Research , homeApril 16, 2026, 5:30 p.m. (Reception at 5 p.m.) | Lewis Lanier, Ph.D., J. Michael Bishop Distinguished Professor and Chair Emeritus, Department of Microbiology and Immunology, University of California, San Francisco; Elected Member, National Academy of Sciences | Maury Strauss Distinguished Public Lecture
-
Home Item
New Insights into Cardiac Mechanobiology: Role of Caveolar Nanodomains in Mechano-electrochemical Signal Transduction , homeApril 17, 2026, 11:00 a.m. | Alexey Glukhov, Ph.D., Associate Professor of Cardiovascular Medicine, UW-Madison Wisconsin Institutes for Medical Research, University of Wisconsin | Co-Sponsored by the Center for Vascular and Heart Research, Fralin Biomedical Research Institute
-
Home Item
Advancing the Treatment of Traumatic Stress and Addictions: How Data Science Can Move the Field Forward , homeMay 1, 2026, 11:00 a.m. | Denise Hien, Ph.D., Helen E. Chaney Endowed Chair in Alcohol Studies, Distinguished Professor, Rutgers Center of Alcohol & Substance Use Studies, Graduate School of Applied and Professional Psychology, Rutgers University-New Brunswick | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and Addiction Recovery Research Center